Initial interim 52-week results from Phase 2b Population Extension cohort of PRISM clinical trial to be presented by Dante Pieramici, M.D., a ...

Oxford, UK – 5 February 2025: OXB (LSE: OXB), a quality and innovation-led cell and gene therapy CDMO, today announces the appointment of Jefferies International Limited ("Jefferies") as its Joint ...

KeyBanc analyst Justin Patterson raised the firm’s price target on Trade Desk (TTD) to $142 from $140 and keeps an Overweight rating on the ...

Axogen (AXGN) announced the appointment of Jesse Bishop as Vice President of Regulatory Affairs. Bishop will report to Michael Dale, President, ...

CARGO elects to discontinue FIRCE-1, a Phase 2 clinical study of firicabtagene autoleucel (firi-cel)1; Company believes results do not support a ...

Authors Trey Grainger, Doug Turnbull, Max Irwin, release book and create online hub to inspire, educate, and showcase new breakthroughs in ...

Transgene’s programs utilize viral vector technology with the goal of indirectly or directly killing cancer cells. The Company’s clinical-stage programs consist of a portfolio of therapeutic vaccines ...

The firm this month introduced its platform-independent GPU-accelerated vector indexing feature. This service is said to delivers up to 10x faster index-building times while using GPUs that rival ...

Resources announced new drilling results on its Golden Crest Project. Two distinctly different styles and ages of gold ...

Tax advantages offered by PEA-PME and PEA are only available to French residents. *Shares of European companies with fewer than 5,000 employees and an annual revenue of less than €1.5 billion or total ...

Revenues increased 7.9% to $108.2 million in the third quarter of 2025 from $100.3 million in the third quarter of 2024;Organic growth of 3.5% ...

Xian Huang received a 2024 Global Recognition Award for advancing AI and financial technologies through innovative marketing.